How to read this section: We test whether three price-based signals —
12-month momentum (trailing stock return), realized volatility (annualized standard deviation of daily returns), and
relative strength (stock return minus S&P 500 return) — predict next-quarter fundamental outcomes:
revenue growth, operating margin change, and ROE change (all year-over-year to remove seasonality).
Each cell shows the Pearson correlation (r) between signal at quarter Q and outcome at quarter Q+1.
Values closer to +1 or −1 indicate stronger predictive relationships. “n” is the number of quarterly observations.
The correlation analysis spanning 45 quarters (2015Q1‑2026Q1) finds that none of the examined price signals—12‑month momentum, realized volatility, or relative strength—exhibit strong predictive power for Select Medical Holdings Corporation's core fundamentals. The strongest observed relationships are modest: realized volatility correlates positively with ROE change (r=0.329, p=0.035) and relative strength shows a similar link to ROE change (r=0.314, p=0.045). Both reach conventional significance at the 5% level but fall below the |r|≥0.6 threshold for strong predictive relevance. Overall, the data suggest that price dynamics capture only limited information about future revenue growth, margin shifts, or profitability changes for this business.
Realized volatility correlates with ROE change (r=0.329, p=0.035) – the strongest statistically significant link observed.
Relative strength also relates to ROE change (r=0.314, p=0.045), suggesting price‑strength metrics capture some profitability dynamics.
All momentum‑based correlations are weak and non‑significant (e.g., revenue growth r=0.161, p=0.315).
No signal reaches the |r|≥0.6 threshold for strong predictive power across any fundamental metric.
Limitations: Sample size is limited to 45 quarterly observations, reducing statistical power and increasing susceptibility to outliers. Correlations do not imply causation; observed links may be driven by common external factors rather than a direct price‑fundamental relationship. The analysis assumes stationarity across the entire period, ignoring potential regime shifts (e.g., macroeconomic cycles) that could alter signal effectiveness.
SEM
For Select Medical Holdings Corporation, the analysis yields no statistically robust signals linking price momentum to any fundamental outcome; the highest momentum‑revenue growth correlation is r=0.161 (p=0.315), well within the weak range. Realized volatility demonstrates a marginally significant positive association with ROE change (r=0.329, p=0.035) and a weaker link to margin change (r=0.060, p=0.708). Relative strength mirrors this pattern, showing a modest yet statistically significant correlation with ROE change (r=0.314, p=0.045) but only weak ties to revenue growth (r=0.229, p=0.150). The limited magnitude of these coefficients implies that while price swings may occasionally reflect shifts in profitability, they are not reliable leading indicators for this company’s financial performance.